Multiple sclerosis and the limits of classical autoimmune theory - Scorecard - MDSpire

Multiple sclerosis and the limits of classical autoimmune theory

  • By

  • Hedström, Anna Karin

  • Piehl, Fredrik

  • June 5, 2026

  • 0 min

Share

Clinical Scorecard: Reevaluating Classical Autoimmune Theory in the Context of Multiple Sclerosis

At a Glance

CategoryDetail
Condition
Key MechanismsImmune-mediated mechanisms, neurodegeneration (which can occur independently of inflammatory activity), and disability accumulation.
Target Population
Care Setting

Key Highlights

  • Traditional autoimmune disease concepts emphasize genetic susceptibility and inflammation.
  • MS shows that neurodegeneration can occur independently of inflammatory activity.
  • The review critiques linear models of autoimmune disease progression.
  • It highlights the need for theoretical refinement in understanding autoimmune diseases.
  • MS serves as a case study for examining broader issues in autoimmune theory.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Patients diagnosed with Multiple Sclerosis.

          Immunomodulatory therapies have been developed based on traditional autoimmune concepts.

          Clinical Best Practices

          • Consider the uncoupling of inflammatory activity and clinical progression in MS.
          • Incorporate temporal dynamics and tissue-specific responses into treatment models.

          Related Resources & Content

            Original Source(s)

            Multiple sclerosis and the limits of classical autoimmune theory

            • by Hedström, Anna Karin , Piehl, Fredrik

            • June 5, 2026

            Related Content

            Bile acid metabolomics reveals distinct immunometabolic niches and enables accurate diagnosis of AQP4-IgG–seronegative NMOSD

            Oculomics: Beyond the Buzzword

            Joseph J. Pizzimenti, OD, FAAO, FORS, discusses the capabilities of oculomics in retina and neuro-ophthalmology,

            A combined therapeutic approach: extracorporeal shock wave therapy and botulinum toxin in multiple sclerosis-related spasticity